Key result
Higher CMR-derived superior vena cava flow index was associated with a 30% lower hazard of death or heart transplant referral/listing per 0.1 L/min/m² increase (HR 0.70, 95% CI 0.50-0.92, p=0.008).
Why the study?
Robust imaging-based predictors of adverse events after the Fontan procedure are limited, and the prognostic value of CMR-derived flow parameters in patients at moderate altitude is not well defined.
Does CMR-derived superior vena cava flow index predict the composite outcome of death or heart transplant referral/listing in post-Fontan patients residing at moderate altitude?
Cohort (n=182)
No
Does CMR-derived superior vena cava flow index predict the composite outcome of death or heart transplant referral/listing in post-Fontan patients residing at moderate altitude?
In Fontan patients residing at moderate altitude, reduced CMR-derived superior vena cava flow index is an independent predictor of death or heart transplantation referral/listing, highlighting the prognostic value of systemic venous return assessment beyond standard ventricular volumetrics.
Answers are grounded in this paper and cite their sources.
SVC flow index was associated with lower event risk in Fontan patients; hypothesis-generating and requires prospective validation before clinical use.
Background Long-term outcomes following the Fontan procedure remain heterogeneous, and robust imaging-based predictors of adverse events are limited. Patients residing at moderate-altitude may experience additional pulmonary vascular stress; however, the prognostic value of cardiovascular magnetic resonance (CMR)–derived flow parameters in this population are not well defined. Methods We performed a retrospective cohort study of Fontan patients followed at a single moderate-altitude center who were ≥5 years post-Fontan and had undergone comprehensive CMR exams. Demographic, anatomic, and surgical data were collected. CMR-derived variables included indexed ventricular volumes and function, systemic arterial dimensions, and flow indices in the ascending and descending aorta, superior vena cava (SVC), inferior vena cava, and branch pulmonary arteries. The primary composite outcome was death or referral/listing for heart transplantation. Time-to-event analyses from the time of CMR were performed using Kaplan–Meier estimates and Cox proportional hazards regression. Results A total of 182 Fontan patients were included (median age at Fontan 3.2 years [interquartile range (IQR) 2.6–3.9]; median time from Fontan to CMR 10.9 years [IQR 7.7–14.2]). Over a median follow-up of 4.7 years following CMR (IQR 3.1–6.6), 14 patients (7.7%) experienced the primary outcome. In univariable Cox regression, a higher SVC flow index was significantly associated with a lower risk of the primary outcome [hazard ratio [HR] 0.70 per 0.1 L/min/m 2 increase; 95% confidence interval [CI] 0.50–0.92; p = 0.008]. Conclusions In this moderate-altitude Fontan cohort, reduced CMR-derived SVC flow index was significantly associated with the primary outcome. This finding suggests that systemic venous flow merits further investigation as a prognostic marker in the Fontan population.
No takes yet. Share an insight, caveat, or question.
Platnick et al. (2026) conducted a cohort in Single-ventricle congenital heart disease after Fontan palliation (n=182). Cardiovascular magnetic resonance–derived superior vena cava (SVC) flow index (per 0.1 L/min/m² increase) vs. Lower SVC flow index / continuous comparison was evaluated on Composite adverse Fontan outcome of death or referral/listing for heart transplantation (HR 0.70 per 0.1 L/min/m² increase, 95% CI 0.50-0.92, p=0.008). Higher CMR-derived superior vena cava flow index was associated with a 30% lower hazard of death or heart transplant referral/listing per 0.1 L/min/m² increase (HR 0.70, 95% CI 0.50-0.92, p=0.008).
Synapse has enriched 10 related papers. Consider them for comparative context: